Ars Pharmaceuticals, Inc. Files SEC Form 8-K, Current Report: (Oct. 15, 2024).

Ars Pharmaceuticals, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on October 15, 2024. The filing contains information about material events or corporate changes that are important to investors. The company's contact information is located in San Diego, California, and the filing can be accessed on the SEC's website for further details. [Extracted from the article]